References
- Aydın F, Kaklıkkaya N, Bayramoğlu G, Ozkul G, Buruk K, Dinç U, Köse T, Dede R. [Resistance rates of Mycobacterium tuberculosis complex strains isolated from clinical specimens] (Turkish). Mikrobiyol Bul. 2011 Jan;45(1):36–42.
- Bañuls AL, Sanou A, Van Anh NT, Godreuil S. Mycobacterium tuberculosis: ecology and evolution of a human bacterium. J Med Microbiol. 2015 Nov 01;64(11):1261–1269. https://doi.org/10.1099/jmm.0.000171
- Baylan O, Kısa O, Albay A, Dogancı L. Mycobacterium tuberculosis Complex (MTC) strains isolated from tuberculosis cases in our mycobacteriology laboratory and their anti-tuberculosis drug susceptibilities in 2002. Gulhane Tip Derg. 2003;45(3):256–262.
- Churchyard G, Kim P, Shah NS, Rustomjee R, Gandhi N, Mathema B, Dowdy D, Kasmar A, Cardenas V. What we know about tuberculosis transmission: an overview. J Infect Dis. 2017; 216(suppl_6):S629-S635. https://doi.org/10.1093/infdis/jix362
- Coffman J, Chanda-Kapata P, Marais BJ, Kapata N, Zumla A, Negin J. Tuberculosis among older adults in Zambia: burden and characteristics among a neglected group. BMC Public Health. 2017 Dec;17(1):804. https://doi.org/10.1186/s12889-017-4836-0
- Dheda K, Gumbo T, Gandhi NR, Murray M, Theron G, Udwadia Z, Migliori GB, Warren R. Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. Lancet Respir Med. 2014 Apr;2(4):321–338. https://doi.org/10.1016/S2213-2600(14)70031-1
- Dundar D, Sonmez Tamer G. Resistance Rates of Mycobacterium tuberculosis isolates to primary antituberculous agents. Klimik Derg. 2009;22(2):52–54.
- Hwang SM, Hwang KC, Hong YJ, Lee HR, Kim TS, Park KU, Song J, Lee JH, Kim EC. Improving antitubercular drug susceptibility testing with liquid media. Ann Clin Lab Sci. 2014 Spring; 44(2):123–130.
- Karadag A, Tokac M, Guvenli A, Sunbul M, Gunaydin M, Sanic A. Resistance ratio to major anti-tuberculosis drugs of tuberculosis complex bacilli isolated from clinical samples. ANKEM Derg. 2004;18(4):189–192.
- Karataş M, Kuyucu T, Sevim T. Evaluation of 1753 patients treated with the diagnosis of tuberculosis. Cumhuriyet Med J. 2019 Mar 27;41(1):34–41. https://doi.org/10.7197/223.vi.543017
- Kunduracioğlu A, Karasu I, Bïçmen C, Özsöz A, Erbaycu AE. [Comparison of the performances of MTD Gene-Probe® test, BACTEC 960™ system and Löwenstein-Jensen culture methods in the diagnosis of smear-negative tuberculosis cases] (Turkish). Mikrobiyol Bul. 2013 Jul 29;47(3):417–431. https://doi.org/10.5578/mb.5728
- Kurtoglu MG, Kesli R, Terzi Y, Baykan M. Investigation of the Susceptibilities of Mycobacterium tuberculosıs Complex strains to major anti-tuberculosis drugs with BACTEC MGIT 960 System. Nobel Med. 2011;7(1):42–48.
- Kurtoğlu MG, Ozdemir M, Keşli R, Ozkalp B, Baysal B. [Isolation rate of Mycobacterium tuberculosis complex from patients with suspected tuberculosis and identification of the strains with BACTEC™ NAP and immunochromatographic TB Ag MPT64 Rapid™ Tests] (Turkish). Mikrobiyol Bul. 2011 Apr;45(2):266–273.
- Kwak M, Lee WK, Lim YJ, Lee SH, Ryoo S. Systematic review and meta-analysis of the nitrate reductase assay for drug susceptibility testing of Mycobacterium tuberculosis and the detection limits in liquid medium. J Microbiol Methods. 2017 Oct;141:1–9. https://doi.org/10.1016/j.mimet.2017.07.001
- Linger Y, Kukhtin A, Golova J, Perov A, Lambarqui A, Bryant L, Rudy GB, Dionne K, Fisher SL, Parrish N, et al. Simplified microarray system for simultaneously detecting rifampin, isoniazid, ethambutol, and streptomycin resistance markers in Mycobacterium tuberculosis. J Clin Microbiol. 2014 Jun 01;52(6):2100–2107. https://doi.org/10.1128/JCM.00238-14
- Liu H, Lian L, Jiang Y, Huang M, Tan Y, Zhao X, Zhang J, Yu Q, Liu J, Dong H, et al. Identification of species of nontuberculous mycobacteria clinical isolates from 8 provinces of China. BioMed Res Int. 2016;2016:1–10. https://doi.org/10.1155/2016/2153910
- Mbeha B, Mine M, Motswaledi MS, Dewar J. Nontuberculous mycobacteria, Botswana, 2011–2014. Emerg Infect Dis. 2019 Jul; 25(7):1401–1403. https://doi.org/10.3201/eid2507.181440
- Miotto P, Zhang Y, Cirillo DM, Yam WC. Drug resistance mechanisms and drug susceptibility testing for tuberculosis. Respirology. 2018 Dec;23(12):1098–1113. https://doi.org/10.1111/resp.13393
- Ozmen E, Aslan A, Ucar M, Aydin H, Yilmaz A. Resistance ratios of Mycobacterium tuberculosis Complex strains isolated in Erzurum Regional Tuberculosis Laboratory against major anti-tuberculosis drugs. ANKEM Derg. 2017;31(2):53–58.
- Perincek G, Tabakoglu E, Otkun M, Ozdemir L, Ozdemir B. Resistance rates of Anti-tuberculosis drugs in pulmonary tuberculosis patients producing Mycobacterium Tuberculosis. Turk Thorac J. 2011 Sep 1;12(3):111–113. https://doi.org/10.5152/ttd.2011.25
- Pienaar E, Linderman JJ, Kirschner DE. Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas. PLoS One. 2018 May 10;13(5):e0196322. https://doi.org/10.1371/journal.pone.0196322
- Saglik Bakanligi T.C. Turkiyede Verem Savaşi 2018 Raporu. Ankara (Turkey): Sağlık Bakanlığı Yayın; 2018.
- Şamlı A, İlki A. Comparison of MALDI-TOF MS, nucleic acid hybridization and the MPT64 immunochromatographic test for the identification of Mycobacterium tuberculosis and non-tuberculosis Mycobacterium species. New Microbiol. 2016 Oct;39(4):259–263.
- Saral OB, Sucu N, Boz GA, Erdem M, Koksal İ. Evaluation of combined drug resistance with Bactec method in 442 Mycobacterium tuberculosis strains. Turk Thorac J. 2007;8(3):174–178.
- Spaulding AB, Lai YL, Zelazny AM, Olivier KN, Kadri SS, Prevots DR, Adjemian J. Geographic distribution of nontuberculous mycobacterial species identified among clinical isolates in the United States, 2009–2013. Ann Am Thorac Soc. 2017 Nov;14(11): 1655–1661. https://doi.org/10.1513/AnnalsATS.201611-860OC
- Stagg HR, Lipman MC, McHugh TD, Jenkins HE. Isoniazid-resistant tuberculosis: a cause for concern? Int J Tuberc Lung Dis. 2017 Feb 01;21(2):129–139. https://doi.org/10.5588/ijtld.16.0716
- Tavanaee Sani A, Shakiba A, Salehi M, Bahrami Taghanaki HR, Ayati Fard SF, Ghazvini K. Epidemiological characterization of drug resistance among Mycobacterium tuberculosis isolated from patients in Northeast of Iran during 2012–2013. BioMed Res Int. 2015;2015:1–6. https://doi.org/10.1155/2015/747085
- Taylan M, Yilmaz S, Kaya H, Demir M, Selimoglu-Sen H, Sezgi C, Abakay O, Tanrıkulu AC, Abakay A. Tuberculosis control status of Diyarbakir province between the years 2005–2010. Dicle Med J. 2015;42(2):227–234.
- Waters V, Ratjen F. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Cochrane Database Syst Rev. 2016;12:CD010004. https://doi.org/10.1002/14651858.CD010004.pub4
- WHO. Global tuberculosis report 2019. Geneva (Switzerland): World Health Organization; 2019.
- WHO. The use of liquid medium for culture and DST [Internet]. Geneva (Switzerland): World Health Organization; 2007 [cited 2019 Dec 16]. Available from: https://www.who.int/tb/laboratory/policy_liquid_medium_for_culture_dst/en/